10-Q: Aimei Health Terminates Business Combination, Faces Going Concern Doubt

Aimei Health Technology Co., Ltd. announced the termination of its business combination with United Hydrogen Group Inc. and faces substantial doubt regarding its ability to continue as a going concern.

Summary

• Aimei Health Technology Co., Ltd. has terminated its previously announced business combination agreement with United Hydrogen Group Inc. as of July 7, 2026.
• The company reported a net loss of $37,704 for the six months ended June 30, 2026, compared to a net income of $609,632 for the same period in 2025.
• As of June 30, 2026, the company had $1,466 in its operating bank account and $12,488,393 in its Trust Account, with a working capital deficit of $3,794,718.
• Management has determined that the company's ability to continue as a going concern is subject to substantial doubt if a business combination is not consummated within the prescribed period.
• The company continues to evaluate potential business combination opportunities.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative sentiment due to the termination of the business combination and the ongoing uncertainty regarding future operations and the company's ability to continue as a going concern.

Positives

• The company has $12,488,393 in its Trust Account as of June 30, 2026, providing a buffer for potential redemptions or future operations.
• Interest income earned on the Trust Account was $216,628 for the six months ended June 30, 2026, offsetting some operational costs.

Negatives

• The business combination with United Hydrogen Group Inc. has been terminated, eliminating a previously identified path for business combination.
• The company incurred a net loss of $37,704 for the six months ended June 30, 2026, a significant shift from a net income of $609,632 in the prior year period.
• A working capital deficit of $3,794,718 was reported as of June 30, 2026.
• The company's disclosure controls and procedures were found to be not effective due to material weaknesses in internal controls.
• The company faces substantial doubt regarding its ability to continue as a going concern if a business combination is not completed within the specified timeframe.

Risks

• The company's ability to continue as a going concern is subject to substantial doubt if it fails to consummate a business combination within the prescribed period.
• If a business combination is not completed, the company will cease operations, redeem public shares, and proceed with liquidation, potentially resulting in less than the offering price per unit for shareholders.
• The termination of the business combination with United Hydrogen Group Inc. creates uncertainty regarding the company's future direction and ability to find a suitable target.
• The company has identified material weaknesses in its internal controls over financial reporting, specifically inadequate segregation of duties and insufficient written policies and procedures.

Future Outlook

The company continues to evaluate potential business combination opportunities following the termination of its agreement with United Hydrogen. There is substantial doubt about the company's ability to continue as a going concern if a business combination is not consummated within the specified period.

Management Comments

• Management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares, and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.
• Although the proposed business combination with United Hydrogen was terminated, the Company continues to evaluate potential business combination opportunities and intends to identify and pursue an appropriate target for a future business combination.

Industry Context

StockSavvy.ai notes that the termination of a SPAC's business combination, especially when coupled with going concern uncertainties, is a common but challenging scenario in the SPAC market. The company's focus on healthcare innovation aligns with a sector that has seen significant SPAC activity, but execution remains critical.

Comparison to Industry Standards

• As a blank check company, Aimei Health's financial performance is primarily driven by interest income on its trust account and operational expenses, rather than revenue from ongoing business operations.
• The net loss of $37,704 for the six months ended June 30, 2026, is typical for SPACs in their pre-business combination phase, where expenses are incurred without generating operating revenue.
• The company's cash burn rate, reflected in general, administrative, and operational costs of $254,332 for the six months ended June 30, 2026, needs to be managed carefully to extend its runway for finding a business combination target.

Legal Proceedings

• None reported.

Related Party Transactions

• Extension loans were provided by the Sponsor and United Hydrogen to fund monthly extension payments into the Trust Account.
• Amounts due to a related company for general and administrative services were $1,129,651 as of June 30, 2026.
• The Sponsor provided administrative services, including office space, utilities, and administrative support, for which a monthly fee was paid, though this agreement expired on December 31, 2025, and the Sponsor now provides office space free of charge.

Stakeholder Impact

• Shareholders face uncertainty regarding the company's ability to complete a business combination and the potential for liquidation.
• If liquidation occurs, shareholders may receive less than their initial investment per share.
• Creditors and vendors may face risks if the company cannot meet its obligations, although the company endeavors to have them waive claims on the Trust Account.

Next Steps

• Continue to evaluate potential business combination opportunities.
• Seek to identify and pursue an appropriate target for a future business combination.
• Manage operational expenses to conserve cash and extend the period available to consummate a business combination.

Key Dates

Recommendation

The termination of the business combination, coupled with the substantial doubt about the company's going concern status and material weaknesses in internal controls, presents significant risks. The lack of a clear path forward and the potential for liquidation make it a speculative investment with a high probability of capital loss for existing shareholders.

Keywords

blank check company, business combination, trust account, going concern, termination, financial statements, shareholder redemption, special purpose acquisition company